Global Prevalence of Anxiety, Depression, and Stress Among Patients with Skin Diseases: A Systematic Review and Meta-analysis
- PMID: 38822990
- DOI: 10.1007/s10935-024-00784-0
Global Prevalence of Anxiety, Depression, and Stress Among Patients with Skin Diseases: A Systematic Review and Meta-analysis
Abstract
The changes in human lifestyle over the past few decades have impacted the prevalence of skin diseases within different societies. Skin diseases may result in various physical and mental disorders. The most common mental disorders observed among the patients are stress, anxiety, and depression. This study aims to investigate the global prevalence of anxiety, depression, and stress in patients with skin diseases. In this Systematic Review and Meta-Analysis study, the PubMed, Scopus, Science Direct, Embase, Web of science, and Google Scholar repositories were searched without a lower time limit. Heterogeneity among the identified studies was examined using the I2 index, and accordingly random effects model was adopted for analysis. Data analysis was conducted within the Comprehensive Meta-Analysis software (v. 2). In total, 113 studies were included for the final analysis. The overall pooled prevalence of stress, depression, and anxiety in skin disease patients was found to be 39.4%, 27.2% and 28.8%, respectively. Among patients with psoriasis, acne, vitiligo or atopic dermatitis diseases, the highest number of patients suffering from stress was related to patients with acne (75.7%). The highest prevalence of depression, and anxiety was reported in patients with vitiligo (38.3%) and acne (36.5%), respectively. Considering the high prevalence of mental disorders among patients with skin diseases and recognising the impacts of mental health challenges on patients' well-being, the findings of this study provide valuable insights for identifying specific populations that require targeted interventions for the diagnosis, treatment, and prevention of mental illnesses. Accordingly, healthcare policymakers should incorporate psychological treatment and support measures as integral components of comprehensive care strategies for patients with skin diseases.
Keywords: Anxiety; Depression; Dermatological disease; Skin disease; Stress.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Global prevalence of depression, anxiety, and stress in the elderly population: a systematic review and meta-analysis.BMC Geriatr. 2024 Oct 4;24(1):809. doi: 10.1186/s12877-024-05311-8. BMC Geriatr. 2024. PMID: 39367305 Free PMC article.
-
Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis.Global Health. 2020 Jul 6;16(1):57. doi: 10.1186/s12992-020-00589-w. Global Health. 2020. PMID: 32631403 Free PMC article.
-
The prevalence of stress, anxiety and depression within front-line healthcare workers caring for COVID-19 patients: a systematic review and meta-regression.Hum Resour Health. 2020 Dec 17;18(1):100. doi: 10.1186/s12960-020-00544-1. Hum Resour Health. 2020. PMID: 33334335 Free PMC article.
-
Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.Elife. 2023 Aug 3;12:e85338. doi: 10.7554/eLife.85338. Elife. 2023. PMID: 37534878 Free PMC article.
-
Prevalence of stress, depression, anxiety and sleep disturbance among nurses during the COVID-19 pandemic: A systematic review and meta-analysis.J Psychosom Res. 2021 Feb;141:110343. doi: 10.1016/j.jpsychores.2020.110343. Epub 2020 Dec 17. J Psychosom Res. 2021. PMID: 33360329 Free PMC article.
Cited by
-
Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis.BMC Womens Health. 2025 Mar 6;25(1):101. doi: 10.1186/s12905-025-03625-2. BMC Womens Health. 2025. PMID: 40050796 Free PMC article.
-
The Skin-Brain Axis in Psoriasis and Depression: Roles of Inflammation, Hormones, Neuroendocrine Pathways, Neuropeptides, and the Microbiome.Psoriasis (Auckl). 2025 Aug 18;15:411-428. doi: 10.2147/PTT.S535900. eCollection 2025. Psoriasis (Auckl). 2025. PMID: 40860250 Free PMC article. Review.
References
-
- Ahammed, M., Mamun, M. A., & Uddin, M. S. (2022). A machine learning approach for skin disease detection and classification using image segmentation. Healthcare Analytics, 2, 100122. - DOI
-
- Ahn, H. J., Shin, M. K., Seo, J. K., Jeong, S. J., Cho, A. R., Choi, S. H., et al. (2019). Cross-sectional study of psychiatric comorbidities in patients with atopic dermatitis and nonatopic eczema, urticaria, and psoriasis. Neuropsychiatric Disease and Treatment, 15, 1469–1478. - PubMed - PMC - DOI
-
- Ajose, F. O. A., Parker, R. A., Merrall, E. L. C., Adewuya, A. O., & Zachariah, M. P. (2014). Quantification and comparison of psychiatric distress in African patients with albinism and vitiligo: A 5-year prospective study. Journal of the European Academy of Dermatology and Venereology, 28(7), 925–932. - PubMed - DOI
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous